首页> Internal medicine (Tokyo, Japan)> Resolution of Eosinophilic Pneumonia after Coronavirus Disease 2019 without Systemic Corticosteroids.

Resolution of Eosinophilic Pneumonia after Coronavirus Disease 2019 without Systemic Corticosteroids.

导出 OA

翻译打印收藏纠错

第一作者： Yumiko,Misaki

第一单位： Department of Respiratory Medicine, Graduate School of Medicine, Kyoto University, Japan.

作者： Yumiko,Misaki ^[1] ; Yusuke,Hayashi ^[1] ; Masahiro,Shirata ^[2] ; Kazuhiro,Terada ^[3] ; Akihiko,Yoshizawa ^[3] ; Ryo,Sakamoto ^[4] ; Kohei,Ikezoe ^[1] ; Kiminobu,Tanizawa ^[1] ; Tomohiro,Handa ^[5] ; Toyohiro,Hirai ^[1]

作者单位： Department of Respiratory Medicine, Graduate School of Medicine, Kyoto University, Japan. ^[1] Department of Respiratory Medicine, Graduate School of Medicine, Kyoto University, Japan.;Department of Respiratory Medicine, Kyoto Preventive Medical Center, Japan. ^[2] Department of Diagnostic Pathology, Graduate School of Medicine, Kyoto University, Japan. ^[3] Department of Diagnostic Imaging and Nuclear Medicine, Graduate School of Medicine, Kyoto University, Japan. ^[4] Department of Respiratory Medicine, Graduate School of Medicine, Kyoto University, Japan.;Department of Advanced Medicine for Respiratory Failure, Graduate School of Medicine, Kyoto University, Japan. ^[5]

关键词 COVID-19 COVID-19 vaccines SARS-CoV-2 eosinophilic pneumonia

医学主题词人类(Humans);肺嗜酸粒细胞增多(Pulmonary Eosinophilia);疾病大流行(Pandemics);肾上腺皮质激素类(Adrenal Cortex Hormones)

DOI 10.2169/internalmedicine.1648-23

PMID 37587039

发布时间 2023-12-01

翻译满意度评价：

准确一般字义偏差语意偏离译文作用小提交